Cencora (ABC) Revenue & Revenue Breakdown
Cencora Revenue Highlights
Latest Revenue (Y)
$262.17B
Latest Revenue (Q)
$74.24B
Main Segment (Y)
Pharmaceutical Distribution
Main Geography (Y)
Pharmaceutical Distribution
Cencora Revenue by Period
Cencora Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $262.17B | 9.89% |
| 2022-09-30 | $238.59B | 11.50% |
| 2021-09-30 | $213.99B | 12.69% |
| 2020-09-30 | $189.89B | 5.74% |
| 2019-09-30 | $179.59B | 6.94% |
| 2018-09-30 | $167.94B | 9.66% |
| 2017-09-30 | $153.14B | 4.29% |
| 2016-09-30 | $146.85B | 8.01% |
| 2015-09-30 | $135.96B | 13.71% |
| 2014-09-30 | $119.57B | 35.94% |
| 2013-09-30 | $87.96B | 10.65% |
| 2012-09-30 | $79.49B | -0.91% |
| 2011-09-30 | $80.22B | 2.90% |
| 2010-09-30 | $77.95B | 8.63% |
| 2009-09-30 | $71.76B | 2.24% |
| 2008-09-30 | $70.19B | 6.23% |
| 2007-09-30 | $66.07B | 7.96% |
| 2006-09-30 | $61.20B | 12.14% |
| 2005-09-30 | $54.58B | 2.63% |
| 2004-09-30 | $53.18B | 7.09% |
| 2003-09-30 | $49.66B | 9.78% |
| 2002-09-30 | $45.23B | 179.38% |
| 2001-09-30 | $16.19B | 39.04% |
| 2000-09-30 | $11.65B | 18.74% |
| 1999-09-30 | $9.81B | 13.13% |
| 1998-09-30 | $8.67B | 10.91% |
| 1997-09-30 | $7.82B | 40.78% |
| 1996-09-30 | $5.55B | 18.91% |
| 1995-09-30 | $4.67B | 8.53% |
| 1994-09-30 | $4.30B | - |
Cencora generated $262.17B in revenue during NA 2023, up 9.89% compared to the previous quarter, and up 156.11% compared to the same period a year ago.
Cencora Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $74.24B | 8.52% |
| 2024-03-31 | $68.41B | -5.31% |
| 2023-12-31 | $72.25B | 4.83% |
| 2023-09-30 | $68.92B | 2.95% |
| 2023-06-30 | $66.95B | 5.50% |
| 2023-03-31 | $63.46B | 0.97% |
| 2022-12-31 | $62.85B | 2.73% |
| 2022-09-30 | $61.17B | 1.85% |
| 2022-06-30 | $60.06B | 4.06% |
| 2022-03-31 | $57.72B | -3.20% |
| 2021-12-31 | $59.63B | 1.22% |
| 2021-09-30 | $58.91B | 10.31% |
| 2021-06-30 | $53.41B | 8.65% |
| 2021-03-31 | $49.15B | -6.40% |
| 2020-12-31 | $52.52B | 6.64% |
| 2020-09-30 | $49.24B | 8.55% |
| 2020-06-30 | $45.37B | -4.33% |
| 2020-03-31 | $47.42B | -0.93% |
| 2019-12-31 | $47.86B | 4.88% |
| 2019-09-30 | $45.64B | 0.88% |
| 2019-06-30 | $45.24B | 4.43% |
| 2019-03-31 | $43.32B | -4.57% |
| 2018-12-31 | $45.39B | 4.84% |
| 2018-09-30 | $43.30B | 0.36% |
| 2018-06-30 | $43.14B | 5.14% |
| 2018-03-31 | $41.03B | 1.40% |
| 2017-12-31 | $40.47B | 3.44% |
| 2017-09-30 | $39.12B | 1.07% |
| 2017-06-30 | $38.71B | 4.20% |
| 2017-03-31 | $37.15B | -2.68% |
| 2016-12-31 | $38.17B | 1.62% |
| 2016-09-30 | $37.56B | 1.84% |
| 2016-06-30 | $36.88B | 3.31% |
| 2016-03-31 | $35.70B | -2.75% |
| 2015-12-31 | $36.71B | 3.49% |
| 2015-09-30 | $35.47B | 3.61% |
| 2015-06-30 | $34.23B | 4.79% |
| 2015-03-31 | $32.67B | -2.74% |
| 2014-12-31 | $33.59B | 6.33% |
| 2014-09-30 | $31.59B | 4.09% |
| 2014-06-30 | $30.35B | 6.65% |
| 2014-03-31 | $28.46B | -2.47% |
| 2013-12-31 | $29.18B | 19.24% |
| 2013-09-30 | $24.47B | 11.70% |
| 2013-06-30 | $21.91B | 6.74% |
| 2013-03-31 | $20.52B | -4.39% |
| 2012-12-31 | $21.47B | 11.29% |
| 2012-09-30 | $19.29B | -2.43% |
| 2012-06-30 | $19.77B | -1.50% |
| 2012-03-31 | $20.07B | -1.42% |
| 2011-12-31 | $20.36B | -0.23% |
| 2011-09-30 | $20.41B | 1.22% |
| 2011-06-30 | $20.16B | 2.03% |
| 2011-03-31 | $19.76B | -0.65% |
| 2010-12-31 | $19.89B | 0.88% |
| 2010-09-30 | $19.72B | 0.58% |
| 2010-06-30 | $19.60B | 1.56% |
| 2010-03-31 | $19.30B | -0.18% |
| 2009-12-31 | $19.34B | 3.31% |
| 2009-09-30 | $18.72B | 1.75% |
| 2009-06-30 | $18.39B | 6.25% |
| 2009-03-31 | $17.31B | -0.15% |
| 2008-12-31 | $17.34B | 1.05% |
| 2008-09-30 | $17.16B | -4.66% |
| 2008-06-30 | $18.00B | 0.84% |
| 2008-03-31 | $17.85B | - |
Cencora generated $74.24B in revenue during Q3 2024, up 8.52% compared to the previous quarter, and up 116.99% compared to the same period a year ago.
Cencora Revenue Breakdown
Cencora Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Sep 21 | Sep 20 | Sep 19 | Sep 18 |
|---|---|---|---|---|
| Pharmaceutical Distribution | $198.15B | $182.47B | $172.81B | $161.70B |
| Other Segments | - | $7.53B | $6.87B | $6.33B |
| Global Commercialization Services | - | $3.31B | $2.89B | - |
| MWI Animal Health | - | $4.22B | $3.98B | - |
Cencora's latest annual revenue breakdown by segment (product or service), as of Sep 21: Pharmaceutical Distribution (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Distribution | $51.25B | $49.31B | $47.10B | $50.49B | $47.29B | $43.58B | $45.56B | $46.04B | $43.87B | $43.53B | $41.68B | $43.74B | $41.73B | $41.58B | $39.45B |
| Other Segments | - | - | - | - | $1.99B | $1.80B | $1.60B | $1.60B | $1.59B | - | - | - | - | - | - |
Cencora's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Pharmaceutical Distribution (100.00%).
Cencora Revenue Breakdown by Country
Annual Revenue by Country
| Country | Sep 21 | Sep 20 | Sep 19 | Sep 18 |
|---|---|---|---|---|
| Pharmaceutical Distribution | $198.15B | $182.47B | $172.81B | $161.70B |
| Global Commercialization Services | - | $3.31B | $2.89B | - |
| MWI Animal Health | - | $4.22B | $3.98B | - |
| Other Segments | - | $7.53B | $6.87B | $6.33B |
Cencora's latest annual revenue breakdown by geography, as of Sep 21: Pharmaceutical Distribution (100.00%).
Quarterly Revenue by Country
| Country | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Distribution | $51.25B | $49.31B | $47.10B | $50.49B | $47.29B | $43.58B | $45.56B | $46.04B | $43.87B | $43.53B | $41.68B | $43.74B | $41.73B | $41.58B | $39.45B |
| Other Segments | - | - | - | - | $1.99B | $1.80B | $1.60B | $1.60B | $1.59B | - | - | - | - | - | - |
Cencora's latest quarterly revenue breakdown by geography, as of Sep 21: Pharmaceutical Distribution (100.00%).